Filing Details
- Accession Number:
- 0001209191-21-068212
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-06 20:41:53
- Reporting Period:
- 2021-11-29
- Accepted Time:
- 2021-12-06 20:41:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1826892 | Bioatla Inc. | BCAB | Biological Products, (No Disgnostic Substances) (2836) | 851922320 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1835116 | Eric Sievers | C/O Bioatla, Inc. 11085 Torreyana Road San Diego CA 92121 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-11-29 | 110 | $23.89 | 92,630 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs.
- The range of prices for the shares of Common Stock is from $23.75 to $24.11. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price.
Billionaire Hedge Funds
